Literature DB >> 33248912

Moderate aerobic training modulates cytokines and cortisol profiles in older adults with cognitive abilities.

Ahmad H Alghadir1, Sami A Gabr2, Murad Al-Momani3, Fidaa Al-Momani4.   

Abstract

Excessive expression of cortisol and pro-inflammatory cytokines exerts a negative affect on cognitive functioning and hippocampal structure in older adults. Although the interrelation between cortisol and cytokines was fully elucidated previously, few studies considered how their association with exercise can affect brain structures or play an anti-inflammatory role in preserving cognitive function among older adults. To evaluate both the neuro-protective and anti-inflammatory activities of moderate aerobic exercise in improving cognitive performance among healthy older adults, the serum levels of CRP, TNF-α, IL-6, and cortisol and their correlation with cognitive performance were estimated in all participants. A total of 60 healthy older adults aged 50-85 years were included in this study. The Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) test, colorimetric testing, and ELISA immunoassays were used to measure cognitive abilities; blood sugar; and glycated hemoglobin (HbA1c), cortisol, IL-6, TNF-α, and CRP, respectively, in older adults before and after 12-week exercise interventions. Exactly 50% of the participants showed moderate cognitive impairment (MCI) (LOTCA scores: 84.8 ± 8.2), and the remaining 50% of the participants (n = 30) were diagnosed as normal healthy subjects (LOTCA scores: 98.7 ± 8.1). There was a significant association between cognitive decline in LOTCA scores of motor praxis, vasomotor organization, thinking operations, and attention and concentration and higher levels of cortisol, CRP, TNF-α, and IL-6, as well as adiposity markers BMI and WHR, in the MCI group compared to control subjects. However, significant improvements in the same LOTCA score domains in MCI subjects were recorded along with decrements in the levels of cortisol and cytokine CRP, TNF-α, and IL-6, as well as improved adiposity markers, following a 12-week moderate exercise program. Cognitive performance correlated positively with cortisol levels and negatively with physical activity, adiposity markers, and cytokine levels. Also, in participants with normal and abnormal cortisol profiles, there was a positive interrelation between cytokine levels and cortisol. Moderate aerobic exercise for 12 weeks showed beneficial effects on cognitive performance in older adults. Our results suggest that 12 weeks of aerobic exercise improves cognitive disorders in older adults via modulating stress and pro-inflammatory cytokines. This may have been due to significant changes in the levels of cortisol, IL-6, TNF-α, and CRP, and physical activity may thus be used as non-drug strategy for treating cognitive disorders.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adiposity; Cognitive abilities; Cortisol; Cytokines; LOTCA scores; Physical exercise

Mesh:

Substances:

Year:  2020        PMID: 33248912     DOI: 10.1016/j.cyto.2020.155373

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Effect of intermittent isometric handgrip exercise protocol with short exercise duration on cognitive performance.

Authors:  Shotaro Saito; Takuro Washio; Hironori Watanabe; Soichi Ando; Shigehiko Ogoh
Journal:  J Physiol Sci       Date:  2021-04-06       Impact factor: 2.781

2.  Effects of the Training of Aerobic Function on Clinical Symptoms and Quality of Life in Patients with Medium and Advanced Lung Cancer.

Authors:  Xiangyan Lv; Yan Zhao; Yuqin Wu
Journal:  J Healthc Eng       Date:  2022-03-23       Impact factor: 2.682

3.  Poor Diet, Long Sleep, and Lack of Physical Activity Are Associated with Inflammation among Non-Demented Community-Dwelling Elderly.

Authors:  Maria Basta; Christina Belogianni; Mary Yannakoulia; Ioannis Zaganas; Symeon Panagiotakis; Panagiotis Simos; Alexandros N Vgontzas
Journal:  Healthcare (Basel)       Date:  2022-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.